Phio Pharmaceuticals Net Profit Margin Growth & History (PHIO)
Phio Pharmaceuticals's net profit margin was −42,419.05% for fiscal 2019.
View full Phio Pharmaceuticals company overviewPhio Pharmaceuticals annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | −42,419.05% | −37085.71 pp |
| 2018 | 2018-12-31 | −5,333.33% | +77680.00 pp |
| 2017 | 2017-12-31 | −83,013.33% | −35676.49 pp |
| 2016 | 2016-12-31 | −47,336.84% | −17269.20 pp |
| 2015 | 2015-12-31 | −30,067.65% | — |
| 2013 | 2013-12-31 | −5,244.36% | +8033.99 pp |
| 2012 | 2012-12-31 | −13,278.35% | — |
Phio Pharmaceuticals quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q1 2019 | 2019-03-31 | −10,090.48% | −355.69 pp |
| Q3 2018 | 2018-09-30 | −2,619.30% | — |
| Q2 2018 | 2018-06-30 | −3,277.59% | — |
| Q1 2018 | 2018-03-31 | −9,734.78% | — |
| Q2 2016 | 2016-06-30 | −24,577.78% | — |
| Q1 2016 | 2016-03-31 | −22,310.00% | −13648.24 pp |
| Q1 2015 | 2015-03-31 | −8,661.76% | −785.90 pp |
| Q1 2014 | 2014-03-31 | −7,875.86% | +19288.29 pp |
| Q4 2013 | 2013-12-31 | −8,648.28% | — |
| Q3 2013 | 2013-09-30 | −2,238.04% | +646.17 pp |
| Q2 2013 | 2013-06-30 | −871.56% | — |
| Q1 2013 | 2013-03-31 | −27,164.15% | — |
| Q3 2012 | 2012-09-30 | −2,884.21% | — |
Phio Pharmaceuticals net profit margin trends
Between the periods ended 2012-12-31 and 2019-12-31, Phio Pharmaceuticals's net profit margin decreased from −13,278.35% to −42,419.05%, a change of −29140.70 percentage points. The latest reported quarter, Q1 2019, shows −10,090.48%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Phio Pharmaceuticals source filings ↗